Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease

Omer Toprak1, Mustafa Cirit, Ertap Esi

  • 1Department of Medicine, Division of Nephrology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2372, USA. info@omertoprak.com

Insights

Hyperuricemia, a condition of high uric acid levels, significantly increases the risk of developing contrast-induced nephropathy (CIN) after coronary angiography. This study highlights hyperuricemia as a key predictor for CIN, emphasizing the need for risk assessment in patients undergoing such procedures.

Area of Science:

  • Nephrology
  • Cardiology
  • Urology

Background:

  • Contrast-induced nephropathy (CIN) is a significant concern in patients undergoing cardiovascular procedures.
  • The role of hyperuricemia as a potential risk factor for CIN has not been previously investigated.
  • Understanding novel risk factors is crucial for improving patient outcomes and preventative strategies.

Purpose of the Study:

  • To prospectively evaluate the association between hyperuricemia and the development of CIN.
  • To determine if elevated serum uric acid levels predict CIN in patients undergoing coronary angiography.

Main Methods:

  • Prospective cohort study involving 266 patients with elevated baseline serum creatinine.
  • Patients were stratified into hyperuricemic (serum uric acid ≥7 mg/dL males, ≥6.5 mg/dL females) and normouricemic groups.
  • CIN was defined as a ≥25% increase in serum creatinine within 48 hours post-angiography.

Main Results:

  • CIN incidence was substantially higher in the hyperuricemic group (15.1%) compared to the normouricemic group (2.9%) (P < 0.001).
  • Hyperuricemia (OR 4.71) and multi-vessel coronary involvement (OR 3.59) were independent predictors of CIN.
  • Other risk indicators included hypoalbuminemia and age ≥70 years; hyperuricemic patients experienced longer hospital stays and higher rates of renal replacement therapy.

Conclusions:

  • The study provides strong evidence that hyperuricemia is a significant risk factor for developing contrast-induced nephropathy.
  • Elevated serum uric acid levels should be considered in the risk stratification of patients undergoing procedures involving iodinated contrast media.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Imaging Studies V: Intravenous Urography and Retrograde Pyelography01:22

Imaging Studies V: Intravenous Urography and Retrograde Pyelography

IntroductionIntravenous Urography (IVU) and Retrograde Pyelography (RP) are important diagnostic imaging techniques used to evaluate the urinary system. These methods help identify structural abnormalities, obstructions, and functional issues in the kidneys, ureters, and bladder. Both procedures use iodine-based contrast media to enhance the visibility of urinary tract structures on X-ray images, though they differ in their methods and indications.1. Intravenous Urography (IVU)Intravenous...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...